Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.
Saved in:
| Title: | Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study. |
|---|---|
| Authors: | Scagnoli S; Department of Radiological, Oncological and Pathological Science, 'Sapienza' University of Rome, Rome, Italy., Pisegna S; Department of Experimental Medicine, Sapienza University, Rome, Italy. simona.pisegna@uniroma1.it., Toss A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Caputo R; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy., De Laurentiis M; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy., Palleschi M; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' IRST Meldola IT, Meldola, Italy., de Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' IRST Meldola IT, Meldola, Italy., Cortesi E; Department of Radiological, Oncological and Pathological Science, 'Sapienza' University of Rome, Rome, Italy., Fabbri A; UOC Belcolle Hospital, Viterbo, Italy., Fabi A; Precision Medicine in Senology, Department of Women Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Precision Medicine in Senology, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Paris I; Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Orlandi A; Fondazione Policlinico Universitario Agostino Gemelli IRCCS Comprehensive Cancer Center, Unit of Medical Oncology, Rome, Italy., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hematology (DIPO), University of Milan, Milan, Italy., Criscitiello C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hematology (DIPO), University of Milan, Milan, Italy., Garrone O; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, SC Oncologia Medica, Milan, Italy., Tomasello G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, SC Oncologia Medica, Milan, Italy., D'Auria G; Sandro Pertini Hospital Unit of Medical Oncology, Rome, Italy., Vici P; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori Regina Elena, UOSD Sperimentazioni di fase IV IT, Rome, Italy., Ricevuto E; University of L'Aquila, L'Aquila, Italy., Domati F; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Piombino C; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy., Parola S; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy., Scafetta R; Università Campus Biomedico, Rome, Italy., Cirillo A; Department of Radiological, Oncological and Pathological Science, 'Sapienza' University of Rome, Rome, Italy.; Department of Experimental Medicine, Sapienza University, Rome, Italy., Taurelli Salimbeni B; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy., Di Lisa FS; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori Regina Elena, UOSD Sperimentazioni di fase IV IT, Rome, Italy., Strigari L; IRCSS AOU Bologna, Bologna, Italy., Preissner R; Institute of Physiology and Science-IT, Charité-Universitätsmedizin Berlin, Berlin, Germany., Simmaco M; Laboratory of Clinical Biochemistry, Sant'Andrea University Hospital, Rome, Italy.; Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, Rome, Italy., Santini D; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.; Medical Oncology A, AOU Policlinico Umberto I, Rome, Italy., Marchetti P; Istituto Dermopatico dell'Immacolata IRCCS, Rome, Italy., Botticelli A; Department of Radiological, Oncological and Pathological Science, 'Sapienza' University of Rome, Rome, Italy. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2024 Aug 02; Vol. 10 (1), pp. 68. Date of Electronic Publication: 2024 Aug 02. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4677 |
|---|---|
| DOI: | 10.1038/s41523-024-00682-y |
